|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
AVTX
|
Avalo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CELC
|
Celcuity Inc.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
RAIN
|
Rain Therapeutics Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
THRX
|
Theseus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PAB
|
Patrys Limited
|
AU
|
ASX
|
|
DMPWW
|
Delmar Pharmaceuticals Inc - Warrants [16/08/202
|
US
|
OTC
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|